Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis
Background: Obesity is associated with the development and progression of c hronic kidney disease. Emerging evidence suggests that glucagon-like p eptide-1 receptor agonist could reduce renal damage and albuminuria. Sirtuin 1 (S IRT1) was considered as a crucial regulator in metabolism-related kidne...
Main Authors: | Riying Liang, Meijun Wang, Chang Fu, Hua Liang, Hongrong Deng, Ying Tan, Fen Xu, Mengyin Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2020-10-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/9/9/EC-20-0294.xml |
Similar Items
-
Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
by: Howell R, et al.
Published: (2019-04-01) -
Gut microbiota mediates positive effects of liraglutide on dyslipidemia in mice fed a high-fat diet
by: Li Zhao, et al.
Published: (2022-12-01) -
Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice
by: Yangzhao Zhou, et al.
Published: (2023-09-01) -
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE
by: Bo Liang, et al.
Published: (2020-07-01) -
Liraglutide; A New Hope for Obese Diabetics
by: Ajeet Kumar, et al.
Published: (2020-12-01)